Research

NCT07296094 - Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder

Clinical Trial in Boston, Massachusetts

This study aims to determine the safety and preliminary efficacy of psilocybin-assisted psychotherapy in improving alcohol-related outcomes among adults with severe alcohol use disorder in a a double-blind, dose-comparison concurrent control, randomized trial. Participants will undergo structured psychotherapy and will be randomized to two psilocybin sessions to receive either a full dose (30mg or 40mg) or low dos... Source record lists lead sponsor Brigham and Women's Hospital and overall status Not Yet Recruiting.

Clinical TrialResearch
NCT07296094 - Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder

What They List

  • Psilocybin Clinical Trial
  • Study Screening Information
  • Research Participation Details

Directory Facts

Status
Verified from official/source records
Price
Free study screening / research participation
Hours
Verify with provider
License / Record
NCT07296094
Last Verified
2026-06-12

Location

Brigham and Women's Hospital, Boston, Massachusetts

Source Notes

Discovery row generated from the official ClinicalTrials.gov API record for NCT07296094; status Not Yet Recruiting; sponsor Brigham and Women's Hospital.

Source: https://clinicaltrials.gov/study/NCT07296094

Informational listing only.

MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.